- Report
- August 2022
- 110 Pages
Global
From €4350EUR$4,750USD£3,704GBP
- Report
- January 2022
- 115 Pages
Global
From €4350EUR$4,750USD£3,704GBP
- Report
- October 2023
- 175 Pages
Global
From €4121EUR$4,500USD£3,509GBP
- Report
- January 2023
- 116 Pages
Global
From €4121EUR$4,500USD£3,509GBP
- Report
- March 2024
- 200 Pages
Global
From €3801EUR$4,150USD£3,236GBP
- Report
- December 2023
- 157 Pages
Global
€4575EUR$4,995USD£3,895GBP
- Report
- August 2023
- 220 Pages
Global
€4391EUR$4,795USD£3,739GBP
- Report
- October 2024
- 94 Pages
Global
From €3500EUR$4,094USD£3,084GBP
- Report
- September 2021
- 212 Pages
Global
From €2380EUR$2,598USD£2,026GBP
€3400EUR$3,712USD£2,894GBP
The Hormone Therapy market is a subset of the Endocrine and Metabolic Disorders Drugs market. It includes drugs used to treat conditions related to hormones, such as diabetes, thyroid disorders, and menopause. Hormone Therapy drugs are used to replace hormones that are not being produced in sufficient amounts by the body, or to block the action of hormones that are overproduced. These drugs are typically administered orally, through injections, or through topical creams.
Hormone Therapy drugs are used to treat a variety of conditions, including infertility, polycystic ovary syndrome, and growth hormone deficiency. They are also used to treat certain types of cancer, such as prostate cancer. Hormone Therapy drugs are often used in combination with other treatments, such as chemotherapy or radiation therapy.
Some of the companies in the Hormone Therapy market include Pfizer, Novo Nordisk, Merck, Sanofi, and Eli Lilly. Show Less Read more